Main: +45 31 10 91 91
Fax: +45 77 31 15 09
CVR/VAT no. 31348854
Ordering: +45 29 13 42 24
Are you looking for an exciting job opportunity within the fast-growing field of modern biological sciences? Are you looking for a new career path and would like to make a difference in an innovative and agile organization?
This is a great opportunity for an individual with a background in immunology and experience with single-cell sequencing technologies joining a Denmark-based globally active biotechnology company as a Technical Application Scientist.
We are a fast-growing company providing solutions for immune monitoring within basic science, immunotherapy, transplantation, infectious disease, and autoimmunity. Based on our proprietary technology, we develop and market research reagents and diagnostic assays enabling researchers, drug developers, and clinicians to measure disease-specific immune responses.
You will join a customer-focused, dynamic, US-based commercial team of talented professionals. In your role as Technical Application Scientist, you will be at the interface of sales, marketing, and R&D, and collaborating directly with customers to design, optimize, and troubleshoot their experiments. To be successful in this role, you must have strong technical knowledge within immunology or single-cell genomics with credibility to effectively consult on solutions, products, and technologies with key opinion leaders. You will have the opportunity to become a subject matter expert in the application of immune monitoring technologies while supporting our growing customer base in North America. You will report to the Chief Commercial Officer.
Location: Near any major international airport in the USA (fully remote position).
Your main responsibilities will be to:
In collaboration with the Denmark-based technical support team:
In collaboration with the Denmark-based technical support team, marketing team, product managers, and R&D:
Maintain an understanding of current immune monitoring and competitive technologies and their relevance to immune-oncology, immunotherapy vaccines, and other immune-related diseases.
Participate in conferences and trade shows including booth set up/break down and discussions with customers.
Travel to/from the company headquarters in Copenhagen 2-3 times annually will be necessary.
We offer a great job with development opportunities in a highly motivating, professional, multicultural, and international environment. You will get the opportunity to expand your knowledge in an exciting biological scientific field and work with key researchers. Being part ofa small biotech company provides insights into every part of the company, quickly accelerating your knowledge of how different branches work together and allowing greater access to collaborate with all departments.
Please apply for this position as soon as possible to firstname.lastname@example.org as we will process applications on an ongoing basis. For more information about the position, please contact Henrik M. Pfundheller, Chief Commercial Officer, at email@example.com.
Based in Copenhagen, Denmark, with North American operations based in Fairfax, Virginia, Immudex manufactures MHC Dextramer® for the detection of antigen-specific T cells. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.
Immudex's MHC Dextramer® products are utilized for the quantification or sorting of antigen-specific T cells in life science research, in vitro diagnostics, as well as the development of immunotherapeutics and vaccines. The primary focus is research-use-only products for the immune monitoring of immunotherapy development and monitoring of CMV cellular immunity in transplant and other immune-deficient patients. In Europe, the CE marked Dextramer® CMV Kit is approved for in vitro diagnostic use for the quantification of CMV-specific T cells. USA FDA 510(k) clearance for the CMV kit was granted in March 2017. GMP Grade reagents are available.
Immudex is the sole proprietor of DNA barcoded MHC multimer technology. The dCODE Dextramer® technology is an advanced development of Immudex proprietary MHC Dextramer® reagents, which are superior for the detection of antigen-specific T cells. The dCODE® technology enables massive multiplexing of disease-specific T-cell detection overcoming the limitations of earlier technologies and is compatible with leading single cell analysis systems.